Jack Joseph Rodriguez, MD | |
106 Jefferson Davis Blvd, Suite 120, Natchez, MS 39120-5104 | |
(601) 442-9210 | |
(601) 442-7409 |
Full Name | Jack Joseph Rodriguez |
---|---|
Gender | Male |
Speciality | Hematology/oncology |
Experience | 33 Years |
Location | 106 Jefferson Davis Blvd, Natchez, Mississippi |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184623886 | NPI | - | NPPES |
09015568 | Medicaid | MS | |
00123444 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | 15252 (Mississippi) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Merit Health Natchez | Natchez, MS | Hospital |
Riverland Medical Center | Ferriday, LA | Hospital |
Southwest Ms Regional Medical Center | Mccomb, MS | Hospital |
Franklin Medical Center | Winnsboro, LA | Hospital |
St Dominic-jackson Memorial Hospital | Jackson, MS | Hospital |
Entity Name | Natchez Oncology Clinic Incorporated |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629145719 PECOS PAC ID: 5294806584 Enrollment ID: O20080925000307 |
News Archive
People with schizophrenia have trouble remembering the details of social interactions in all phases of the illness, UCLA researchers report. However, in the early stages of schizophrenia, patients can remember more about these interactions if given hints about context. This finding suggests a potential strategy for memory training.
Novartis announced today that the European Commission approved once-daily Ultibro® Breezhaler® (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). In addition, the Japanese Ministry of Health, Labour and Welfare (MHLW) approved once-daily Ultibro® Inhalation Capsules (glycopyrronium 50 mcg / indacaterol 110 mcg), delivered through the Breezhaler® device, for relief of various symptoms due to airway obstruction in chronic obstructive pulmonary disease (COPD). Ultibro® Breezhaler® / Ultibro® Inhalation Capsules were developed under the name QVA149.
The Saints are going to the Super Bowl and we couldn't be any happier. We wanted to throw out a small lagniappe for our fellow Louisiana residents and offer the free drug card program titled the WhoDatDrugCard.com . This card is available to all residents and can save you as much as 75% off your medication purchase at over 2,000 pharmacies statewide.
A new breast cancer staging system developed by researchers at The University of Texas MD Anderson Cancer Center finds that incorporating tumor biology is a critical prognostic indicator for women who undergo neoadjuvant, or pre-surgical, therapy for breast cancer.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Jack Joseph Rodriguez, MD 400 S Commerce St, Natchez, MS 39120-3506 Ph: (601) 442-9210 | Jack Joseph Rodriguez, MD 106 Jefferson Davis Blvd, Suite 120, Natchez, MS 39120-5104 Ph: (601) 442-9210 |
News Archive
People with schizophrenia have trouble remembering the details of social interactions in all phases of the illness, UCLA researchers report. However, in the early stages of schizophrenia, patients can remember more about these interactions if given hints about context. This finding suggests a potential strategy for memory training.
Novartis announced today that the European Commission approved once-daily Ultibro® Breezhaler® (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). In addition, the Japanese Ministry of Health, Labour and Welfare (MHLW) approved once-daily Ultibro® Inhalation Capsules (glycopyrronium 50 mcg / indacaterol 110 mcg), delivered through the Breezhaler® device, for relief of various symptoms due to airway obstruction in chronic obstructive pulmonary disease (COPD). Ultibro® Breezhaler® / Ultibro® Inhalation Capsules were developed under the name QVA149.
The Saints are going to the Super Bowl and we couldn't be any happier. We wanted to throw out a small lagniappe for our fellow Louisiana residents and offer the free drug card program titled the WhoDatDrugCard.com . This card is available to all residents and can save you as much as 75% off your medication purchase at over 2,000 pharmacies statewide.
A new breast cancer staging system developed by researchers at The University of Texas MD Anderson Cancer Center finds that incorporating tumor biology is a critical prognostic indicator for women who undergo neoadjuvant, or pre-surgical, therapy for breast cancer.
› Verified 2 days ago
Dr. Alphonse Michael Reed, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 55 Sgt Prentiss Dr, Suite 102, Natchez, MS 39120 Phone: 601-445-7352 Fax: 601-445-7353 | |
Dr. Kenneth Sloan Drane, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 329 Highland Blvd, Natchez, MS 39120 Phone: 601-445-0740 Fax: 601-897-4210 | |
Jennifer L. Hebert, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 46 Sergeant Prentiss Dr Ste 201, Natchez, MS 39120 Phone: 601-445-1715 Fax: 601-445-6720 | |
Prof. Vikramaditya Dulam, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 140 Jefferson Davis Blvd, Natchez, MS 39120 Phone: 601-304-9718 Fax: 601-304-9637 | |
Dr. Akinremi Ayodeji Akinwale, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 129 Jefferson Davis Blvd., Natchez, MS 39120 Phone: 601-445-1736 Fax: 601-446-1753 | |
Dr. Thomas Bradford Lemay, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 46 Sgt Prentiss Dr, Suite 204, Natchez Regional Medical Office Building, Natchez, MS 39120 Phone: 601-653-4927 Fax: 601-897-0542 |